Slingshot members are tracking this event:
Abbvie's(ABBV) Upadacitinib (ABT-494) as Monotherapy Results released in Phase 3 Rheumatoid Arthritis Study
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Dec 20, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords Rheumatoid Arthritis, Upadacitinib, Abt-494